|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0013216,
umls-concept:C0034656,
umls-concept:C0043210,
umls-concept:C0183683,
umls-concept:C0278488,
umls-concept:C0344211,
umls-concept:C0439859,
umls-concept:C1171411,
umls-concept:C1317973,
umls-concept:C1328050,
umls-concept:C1513884,
umls-concept:C1521721,
umls-concept:C1707455
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2007-12-31
|
|
pubmed:abstractText |
We conducted a multicenter, randomized trial to compare progression-free survival (PFS), overall survival (OS), and quality of life in women with metastatic breast cancer (MBC) receiving high-dose chemotherapy plus autologous stem-cell transplantation (ASCT; HDCT) compared with standard-dose therapy.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:CoubanStephenS,
pubmed-author:CrumpMichaelM,
pubmed-author:DanceyJanetJ,
pubmed-author:GirouardCarolineC,
pubmed-author:GluckStefanS,
pubmed-author:KirkbridePeterP,
pubmed-author:LevineMarkM,
pubmed-author:MarlinSusanS,
pubmed-author:O'ReillySusanS,
pubmed-author:PritchardKathleen IKI,
pubmed-author:ShepherdLoisL,
pubmed-author:ShoreTsiporahT,
pubmed-author:StewartDougD,
pubmed-author:TuDongshengD
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
37-43
|
|
pubmed:meshHeading |
pubmed-meshheading:18025439-Adult,
pubmed-meshheading:18025439-Aged,
pubmed-meshheading:18025439-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18025439-Bone Neoplasms,
pubmed-meshheading:18025439-Breast Neoplasms,
pubmed-meshheading:18025439-Combined Modality Therapy,
pubmed-meshheading:18025439-Cyclophosphamide,
pubmed-meshheading:18025439-Dose-Response Relationship, Drug,
pubmed-meshheading:18025439-Doxorubicin,
pubmed-meshheading:18025439-Epirubicin,
pubmed-meshheading:18025439-Female,
pubmed-meshheading:18025439-Fluorouracil,
pubmed-meshheading:18025439-Follow-Up Studies,
pubmed-meshheading:18025439-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:18025439-Humans,
pubmed-meshheading:18025439-Liver Neoplasms,
pubmed-meshheading:18025439-Lung Neoplasms,
pubmed-meshheading:18025439-Middle Aged,
pubmed-meshheading:18025439-Quality of Life,
pubmed-meshheading:18025439-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16.
|
|
pubmed:affiliation |
National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada. michael.crump@uhn.on.ca
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study
|
